SMAD4通过抑制CCL20/CCR6介导的炎症抑制结肠炎相关癌变
本研究探讨CCL20/CCR6趋化因子/受体对在SMAD4缺失诱导的结肠炎相关结肠癌变中的作用。人溃疡性结肠炎相关癌中上皮SMAD4缺失与CCL20表达增加及CCR6+细胞增多相关;小鼠中上皮Smad4缺失导致肠道相关淋巴组织增大及免疫细胞募集,而Ccr6缺失可消除这些免疫反应并显著降低结肠炎相关肿瘤发生率。结论:SMAD4抑癌功能的核心在于调控黏膜炎症,关键下游节点是抑制上皮CCL20信号至免疫细胞CCR6。
要点
- 人溃疡性结肠炎相关癌中上皮SMAD4缺失与CCL20表达增加及CCR6+细胞增多相关。
- 小鼠上皮Smad4缺失导致肠道相关淋巴组织增大及免疫细胞(Treg、Th17、树突状细胞)募集。
- Ccr6缺失可消除上述免疫反应并显著降低Smad4缺失小鼠的结肠炎相关肿瘤发生率。
核心结论
- SMAD4在结肠的抑癌功能核心在于调控黏膜炎症,关键下游节点是抑制上皮CCL20信号至免疫细胞CCR6。
研究设计与样本
- 研究包括对人溃疡性结肠炎、结肠癌和直肠癌转录组数据的计算机分析,对人溃疡性结肠炎相关癌组织芯片的CCL20和CCR6免疫组化,以及具有上皮特异性Smad4缺失(伴或不伴Ccr6基因种系缺失)的小鼠接受结肠炎诱导并随访长达3个月,肿瘤经组织学定量,免疫细胞群经流式细胞术和免疫染色分析。
主要发现
- 人溃疡性结肠炎相关癌中,上皮SMAD4缺失与CCL20表达增加及CCR6+细胞增多相关。
- 小鼠结肠上皮Smad4缺失导致肠道相关淋巴组织增大及免疫细胞(尤其T调节细胞、Th17细胞和树突状细胞)募集至结肠上皮和间质。
- Ccr6缺失消除了上述免疫反应,并显著降低了单独Smad4缺失时所观察到的结肠炎相关肿瘤发生率。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We previously reported that colon epithelial cell silencing of Smad4 increased epithelial expression of inflammatory genes, including the chemokine c-c motif chemokine ligand 20 (CCL20), and increased susceptibility to colitis-associated cancer. Here, we examine the role of the chemokine/receptor pair CCL20/c-c motif chemokine receptor 6 (CCR6) in mediating colitis-associated colon carcinogenesis induced by SMAD4 loss. METHODS: In silico analysis of SMAD4, CCL20, and CCR6 messenger RNA expression was performed on published transcriptomic data from human ulcerative colitis (UC), and colon and rectal cancer samples. Immunohistochemistry for CCL20 and CCR6 was performed on human tissue microarrays comprising human UC-associated cancer specimens, Mice with conditional, epithelial-specific Smad4 loss with and without germline deletion of the Ccr6 gene were subjected to colitis and followed for up to 3 months. Tumors were quantified histologically, and immune cell populations were analyzed by flow cytometry and immunostaining. RESULTS: In human UC-associated cancers, loss of epithelial SMAD4 was associated with increased CCL20 expression and CCR6+ cells. SMAD4 loss in mouse colon epithelium led to enlarged gut-associated lymphoid tissues and recruitment of immune cells to the mouse colon epithelium and stroma, particularly T regulatory, Th17, and dendritic cells. Loss of CCR6 abrogated these immune responses and significantly reduced the incidence of colitis-associated tumors observed with loss of SMAD4 alone. CONCLUSIONS: Regulation of mucosal inflammation is central to SMAD4 tumor suppressor function in the colon. A key downstream node in this regulation is suppression of epithelial CCL20 signaling to CCR6 in immune cells. Loss of SMAD4 in the colon epithelium increases CCL20 expression and chemoattraction of CCR6+ immune cells, contributing to greater susceptibility to colon cancer.
引用
- Hanna DN, Smith PM, Novitskiy SV, et al. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation. Gastroenterology. 2022. PMID: 35863523. doi:10.1053/j.gastro.2022.07.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。